ClinicalTrials.Veeva

Menu

Quality-of-life Impact of Newly Formed Digitalized Printed Paper Inserted Into Eyeglasses

H

Hams Hamed Abdelrahman

Status

Enrolling

Conditions

Orbital Deformity

Treatments

Device: Traditional drawing image
Other: Healthy controls
Device: Digitalized printed paper

Study type

Interventional

Funder types

Other

Identifiers

NCT05857189
QoL_2022

Details and patient eligibility

About

A straightforward, user-friendly removable orbital prosthesis is a practical choice for effective rehabilitation in such patients with defective eyes. One of the essential elements for a good recovery is the retention of the prosthesis. The prosthesis can be retained by using a spectacle frame, conformers, adhesives, osseointegrated implants, magnets, or buttons. Only osseointegrated prostheses in the maxillofacial region can use semi-precision attachments.

Full description

Aim: Using of eyeglasses with newly formed digitalized printed paper of mirrored photograph of an intact eye for orbital defected patients to restore the esthetic appearance. An evaluation of the quality of life for patients using temporalized eyeglasses with digitalized printed paper of mirrored photographs of a healthy eye.

Enrollment

18 estimated patients

Sex

All

Ages

6+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with an orbital defective eye (type I).
  • Patients age more than 6 years.
  • Patients with a unilateral enucleated eye.
  • Skin-grafted orbital defects with a lack of natural retentive means either natural undercuts or retaining implants.
  • Patients who are not prone to be received any prosthetic rehabilitation either for financial, age, or transportation problems of material that are needed for fabrication of prosthetic eye.

Exclusion criteria

  • Patients with the bilateral enucleated eye.
  • Patients with primary signs of skin inflammation, infection, or untreated local disease
  • Patients refusing to wear any eyeglasses.
  • Patients with ocular defects.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

18 participants in 3 patient groups

Experimental group
Experimental group
Treatment:
Device: Digitalized printed paper
Control group
Active Comparator group
Treatment:
Device: Traditional drawing image
Healthy control group
Other group
Description:
patients in this group will be observed as a normal reference group
Treatment:
Other: Healthy controls

Trial contacts and locations

1

Loading...

Central trial contact

Ahmed k Farag, BDS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems